Php43 - Evidence for High Risk Class Medical Devices Versus New Drugs in Germany: What’s the Difference?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.938
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pmd175 - Market Entry of New Medical Devices in Germany - Outpatient Sector

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Divergent Evidence Requirements Comparing the Authorization and Reimbursement Processes of High-Risk Medical Devices – The European Situation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Latest Evidence on Sulfonylureas: What’s New?

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Clinical Evidence in the Regulation of Medical Devices

Research Ethics
PhilosophyEducation
2016English

Pmd133 - Success Factors for §137h SGB v Assessment of Medical Devices in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Translation vs Localization: What’s the Difference?

Journal of Siberian Federal University - Humanities and Social Sciences
Anthropology
2018English

New French Coverage With Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Abortifacient Drugs and Devices: Medical and Moral Dilemmas

Linacre quarterly, The
Health PolicyPhilosophy
1990English

What’s New in VTE Risk and Prevention in Orthopedic Surgery

Research and Practice in Thrombosis and Haemostasis
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy